Inter-American Development Bank
facebook
twitter
youtube
linkedin
instagram
Abierto al públicoBeyond BordersCaribbean Development TrendsCiudades SosteniblesEnergía para el FuturoEnfoque EducaciónFactor TrabajoGente SaludableGestión fiscalGobernarteIdeas MatterIdeas que CuentanIdeaçãoImpactoIndustrias CreativasLa Maleta AbiertaMoviliblogMás Allá de las FronterasNegocios SosteniblesPrimeros PasosPuntos sobre la iSeguridad CiudadanaSostenibilidadVolvamos a la fuente¿Y si hablamos de igualdad?Home
Citizen Security and Justice Creative Industries Development Effectiveness Early Childhood Development Education Energy Envirnment. Climate Change and Safeguards Fiscal policy and management Gender and Diversity Health Labor and pensions Open Knowledge Public management Science, Technology and Innovation  Trade and Regional Integration Urban Development and Housing Water and Sanitation
  • Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer

Gente Saludable

IDB

  • HOME
  • CATEGORIES
    • Aging and Dependency
    • Courses and Seminars
    • Digital Transformation
    • Public health and nutrition
    • Healthy Lifestyle
    • Health services
    • Health Spending and Financing
    • Women’s and Children’s Health
  • authors
  • English
    • Spanish
    • Portuguese
Estetoscopio con calculadora

The hidden beauty of costing health

May 4, 2021 por Ursula Giedion - Pamela Góngora - Rodrigo Muñoz - Hugo Godoy Leave a Comment


A major policy focus in moving toward UHC (Universal Health Coverage) has been on the key policy question: what services should be made available and under what conditions? And health benefits packages (HBPs) are an answer to this question as they refer to explicitly defined services that can be feasibly financed and provided under the actual circumstances in which a given country finds itself.5  

Costing health benefits packages rarely awakens passions in those applying, studying or promoting it. Nobody doubts it is important, but it is often seen as the work of accountants, not policy makers. The talk mostly focuses on how to determine unit costs and frequencies and how to project these variables in the future.  

But costing is so much more than knowing the total cost of a set of prioritized services. When making the right questions it becomes a powerful tool on the road towards universal health coverage (UHC) that is, in ensuring that all people can access the health services they need. One of these key questions is how much more resources will we need to adopt the HBP and the advised costing expert will righteously say: “this will depend on where you are now regarding the coverage level of the prioritized services and where you want to go in the short, medium and long term”. 

Indeed, policy makers are often not very keen in knowing the total cost of a HBP (unless there is a clear separation of the financing and delivery function) for two reasons. First, it is illusory to think that health systems will reallocate their total budgets to the HBP. Most LMIC struggle with tight budgets so diverting resources by disinvestment in currently provided services will not be politically feasible. Second, no country starts from scratch and, more often than not, countries already do provide some coverage for most of the health services included in the newly designed HBPs and they already use part of their resources to that end.  

Infinite needs, finite resources 

The question then is not so much how much it would cost them to provide a certain HBP but rather how much more money they would have to mobilize to close the coverage gap. Now, when answering that question, the evidence of currently low coverage levels pops up and becomes itself an important political instrument to promote HBPs as a tool to provide real access to the most important services needed by a population (as opposed to an aspirational wish list put on a paper).   

The usefulness of costing the gap has become more evident to us in a recent IDB project by Criteria Network meant to design and cost a HBP for Honduras. Using cost-effectiveness, equity and financial protection criteria, we identified and ranked 74 priority health interventions. Then we calculated intervention unit costs “bottom-up” using normative assumptions about all required inputs (personnel, drugs, exams, etc.), and projected the population in need for each intervention using various sources, such as the Global Burden of Disease 2017. To answer how much more do we need we had to estimate current coverage levels for each intervention using utilization data reported by health centers and hospitals, and present policy scenarios on how to increase them. For example, only 35% of children under 5 with acute lower respiratory infections have coverage.  

The 44 dollars gap  

The per capita cost of the HBP including the 74 prioritized health interventions under current coverage levels, was estimated at $29 USD annually. If assuming effective 100% coverage, the same package would cost approximately $73 USD. Hence, if the country wants to guarantee to everyone the 74 most essential health interventions, they will need an additional spending of roughly $44 USD per person, an amount that accounts to over 50% the current health budget Mobilizing these additional resources in one or even two years’ time is not realistic. It is equally unlikely that any country will stop providing most non-prioritized services to re-allocate resources towards the designed HBP. A more realistic aspiration would be to allocate every health budget addition to ensure a progressive expansion of coverage of the 74 prioritised interventions, to reach a 70% coverage in 4 years’ time. Alternatively, the HBP could be first offered to the most vulnerable population groups and then be gradually scaled up to the rest of the country. Also, where feasible, the government could also progressively remove some ineffective programs and redirect those resources towards the most cost-effective and equity-enhancing interventions. 

Do you want to know more about estimating health costs? Reserve a spot in our next webinar (in Spanish). Register here

Other benefits of the costing exercise 

The usefulness of the costing exercise is not limited to the determination of the total cost of a HBP and calculating the cost of the coverage. The analysis of utilization and prices data that was necessary to define the unit cost of health care interventions included in the HBP, rose questions on important issues, such as the staff mix required to achieve UHC or which specific drugs could be acquired at better prices or through better procurement mechanisms. This means that costing has also the potential to highlight some of the current inefficiencies in the health system, information that policymakers can use to make the necessary adjustments and release resources that could be used to increase the level of coverage. 

Designing a HBP is a multistep process, in which all steps are interdependent. The costing of the prioritised health interventions is not the exception. For a HBP to potentially have a real and direct influence on resource allocation, costing is a key building block, not only to estimate the resources required but also to understand the current coverage of the prioritized health interventions and different trajectories of eventually reaching effective coverage and their cost. This is particularly relevant in low- and middle-income countries, where the coverage gap for most basic and low-cost health interventions can be considerably high and HBP design is often more about scaling up the current level of health service coverage than of adding new services.  

Costing is a key building block of explicit priority setting and HBP design and it is a much more powerful tool than what most, policymakers and analysts alike, might think. 


Filed Under: Health Spending and Financing Tagged With: Banco Interamericano de Desarrollo, BID, políticas públicas, Salud

Ursula Giedion

Ursula Giedion coordinates the Criteria Network of the Inter-American Development Bank.

Pamela Góngora

Senior Associate in the Social Protection and Health Division of the IDB, with more than fifteen years of experience in health economics and policy, with special emphasis on health prioritization, economic evaluations and interventions focused on reducing the burden of non-communicable diseases. Pamela is an Economist, Master in Economic Policy and Master in Social Policy and Planning from the University of London. She also completed a PhD in Population Health/Health Economic Evaluation at the University of Oxford (UK). In the past, Pamela has worked as a project manager and economic studies in the private sector, as an advisor to the Colombian Minister of Health and as an independent consultant in health program evaluation.

Rodrigo Muñoz

Consultant at the Social Protection and Health Division at the Inter-American Development Bank and health costing expert.

Hugo Godoy

Hugo Godoy es especialista líder en la División de Protección Social y Salud del Banco Interamericano de Desarrollo.

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Follow Us

Subscribe

Search

Health

Latin American and Caribbean countries face multiple challenges to provide quality healthcare for their citizens. In this blog, IDB Specialists and international experts discuss current health issues and hope to build a dynamic dialogue through your comments.

Similar Posts

  • 10 Take-Aways on How the Region Can Improve Health Spending Efficiency
  • Is it possible to achieve more health per dollar spent? Potential gains by improving health spending efficiency
  • The Hidden Trade-off of High-Cost Drugs
  • 300+ Economists around the World ask for “Health for All”
  • Can We Afford a Healthy Future? 

Footer

Banco Interamericano de Desarrollo
facebook
twitter
youtube
youtube
youtube

    Blog posts written by Bank employees:

    Copyright © Inter-American Development Bank ("IDB"). This work is licensed under a Creative Commons IGO 3.0 Attribution-NonCommercial-NoDerivatives. (CC-IGO 3.0 BY-NC-ND) license and may be reproduced with attribution to the IDB and for any non-commercial purpose. No derivative work is allowed. Any dispute related to the use of the works of the IDB that cannot be settled amicably shall be submitted to arbitration pursuant to the UNCITRAL rules. The use of the IDB's name for any purpose other than for attribution, and the use of IDB's logo shall be subject to a separate written license agreement between the IDB and the user and is not authorized as part of this CC- IGO license. Note that link provided above includes additional terms and conditions of the license.


    For blogs written by external parties:

    For questions concerning copyright for authors that are not IADB employees please complete the contact form for this blog.

    The opinions expressed in this blog are those of the authors and do not necessarily reflect the views of the IDB, its Board of Directors, or the countries they represent.

    Attribution: in addition to giving attribution to the respective author and copyright owner, as appropriate, we would appreciate if you could include a link that remits back the IDB Blogs website.



    Privacy Policy

    Derechos de autor © 2025 · Magazine Pro en Genesis Framework · WordPress · Log in

    Banco Interamericano de Desarrollo

    Aviso Legal

    Las opiniones expresadas en estos blogs son las de los autores y no necesariamente reflejan las opiniones del Banco Interamericano de Desarrollo, sus directivas, la Asamblea de Gobernadores o sus países miembros.

    facebook
    twitter
    youtube
    This site uses cookies to optimize functionality and give you the best possible experience. If you continue to navigate this website beyond this page, cookies will be placed on your browser.
    To learn more about cookies, click here
    X
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
    Non-necessary
    Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
    SAVE & ACCEPT